- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis.
Showing 1–12 of 45 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD80 , CD86 |
Fusion protein |
Orencia® |
25 mg/mL |
yes |
5 mg |
-80°C |
02/2023 |
194,40 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
– |
4 mg |
-80°C |
11/2023 |
438,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hukyndra® |
100 mg/mL |
– |
2 mg |
-80°C |
10/2023 |
344,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
– |
4 mg |
-80°C |
03/2023 |
394,20 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Yuflyma® |
100 mg/mL |
– |
4 mg |
-80°C |
02/2024 |
344,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
09/2018 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
12/2018 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
03/2019 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
03/2019 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
07/2019 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
12/2019 |
394,20 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
03/2020 |
394,20 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Idacio® |
50 mg/mL |
– |
2 mg |
-80°C |
10/2023 |
345,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Imraldi® |
50 mg/mL |
– |
2 mg |
-80 °C |
10/2023 |
295,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hyrimoz® |
50 mg/mL |
– |
2 mg |
-80°C |
06/2024 |
295,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Erelzi® |
50 mg/mL |
– |
4 mg |
-80°C |
04/2023 |
237,60 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
6 mg |
-80°C |
01/2024 |
266,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Benepali® |
50 mg/mL |
– |
4 mg |
-80°C |
11/2023 |
264,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
25 mg/mL |
– |
2 mg |
-80°C |
02/2019 |
171,90 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
04/2019 |
171,90 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
06/2019 |
171,90 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
08/2019 |
171,90 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
25 mg/mL |
– |
2 mg |
-80°C |
12/2019 |
171,90 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
10/2019 |
171,90 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
04/2020 |
171,90 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Nepexto® |
50 mg/mL |
– |
4 mg |
-80 °C |
08/2023 |
237,60 € |
||
IL-23 |
Monoclonal Antibody |
Tremfya® |
100 mg/mL |
yes |
4 mg |
-80°C |
12/2023 |
684,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Remsima® |
10 mg/mL |
– |
3 mg |
tba |
tba |
233,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
11/2019 |
178,20 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
08/2019 |
178,20 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin